David J. Waxman
David J. Waxman is Professor of Cell and Molecular Biology and Professor of Medicine at Boston University. He received his Ph.D. in Biochemistry and Molecular Biology from Harvard University in 1980 and conducted post-doctoral research in enzymology as a Damon Runyon Cancer Fund Fellow at MIT. He is an active member of many external scientific advisory boards, review panels, professional societies, and journal editorial boards. Dr. Waxman is leading authority in the field of cytochrome P450 research, and has made numerous contributions to our understanding of the biochemistry, pharmacology and endocrine regulation of this family of enzymes (http://blogs.bu.edu/djwweb). He has extensive experience in cancer pharmacology with a focus on chemotherapeutic prodrugs and anti-angiogenic agents, and is a pioneer in the field of cancer gene therapy using prodrug-activating P450 genes. In 2006, he was ranked 13 of the top 100 researchers in pharmacology and toxicology by Thomson-ISI based on publication citations. He has frequently appeared as invited speaker at national and international conferences and major symposia and has contributed more than 200 articles to peer-reviewed professional journals.
Biography Updated on 4 February 2009